September 30, 2014 12:12 PM ET

Biotechnology

Company Overview of AmVac AG

Company Overview

AmVac AG develops vaccines for the treatment and prevention of widespread infections and urogenital conditions. The company offers Gynevac, a platform for the treatment of urogenital conditions; MALP platform that enables the generation of a new class of vaccine adjuvants, which are mixed with vaccines to increase their efficacy; and Sendai, a virus vector platform that enables the generation of a new class of ‘semi-live’ vaccines for the prevention of respiratory syncytial virus infections. It also offers vaccines for the prevention of seasonal and pandemic influenza, chronic prostatitis, and benign prostate hyperplasia; and acute, subacute, and chronic gynecological inflammations. AmVac AG...

Metallstraße 4

Zug,  6300

Switzerland

Founded in 2005

Phone:

41 41 725 32 30

Fax:

41 41 725 32 39

Key Executives for AmVac AG

Chairman of The Supervisory Board
Chief Operating Officer
Head of Research & Development
Chief Information Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioXpress Therapeutics SA Europe
Biospectra AG Europe
Pevion Biotech AG Europe
Manteia S.A. Europe
Stemergie Biotechnology SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AmVac AG, please visit www.amvac.ch. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.